Antibody Production Market by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies), Process (Downstream Processing, Filtration, Upstream Processing), End-User - Global Forecast 2024-2030
Antibody Production Market by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies), Process (Downstream Processing, Filtration, Upstream Processing), End-User - Global Forecast 2024-2030
The Antibody Production Market size was estimated at USD 17.97 billion in 2023 and expected to reach USD 20.16 billion in 2024, at a CAGR 12.40% to reach USD 40.77 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Antibody Production Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antibody Production Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Antibody Production Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., AstraZeneca PLC, Biogen Inc., Bristol-Myers Squibb Company, Cell Signaling Technology, Inc., Eppendorf AG, F. Hoffmann-La Roche Ltd., Fibercell Systems Inc, GE HealthCare Technologies Inc., Genmab A/S, GenScript Biotech Corporation, Gilead Sciences, Inc., INTEGRA Biosciences AG, Merck KGaA, Novartis AG, Novo Nordisk A/S, Pall Corporation, Pfizer Inc., ProteoGenix, Sanofi S.A., Sartorius AG, Teva Pharmaceutical Industries Ltd., The Antibody Company, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Antibody Production Market to forecast the revenues and analyze trends in each of the following sub-markets:
Antibody Type
Monoclonal Antibodies
Polyclonal Antibodies
Process
Downstream Processing
Chromatography Resins
Chromatography Systems
Filtration
Consumables & Accessories
Filtration Systms
Upstream Processing
Bioreactors
Consumables
End-User
Contract Research Organizations (CROs)
Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Research Institutes & Academic Centers
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom The report offers valuable insights on the following aspects:
Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
What is the market size and forecast of the Antibody Production Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antibody Production Market?
What are the technology trends and regulatory frameworks in the Antibody Production Market?
What is the market share of the leading vendors in the Antibody Production Market?
Which modes and strategic moves are suitable for entering the Antibody Production Market?
Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Antibody Production Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic diseases among population
5.1.1.2. Growing demand for targeted therapies and personalized medicines
5.1.1.3. Modernization of healthcare infrastructure and increase in healthcare expenditure
5.1.2. Restraints
5.1.2.1. High costs associated with antibody production
5.1.3. Opportunities
5.1.3.1. Robust research activities to introduce novel plant‐made monoclonal antibody
5.1.3.2. Emerging applications of bispecific antibodies in cancer immunotherapy
5.1.4. Challenges
5.1.4.1. Stringent regulatory frameworks for antibody production
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Antibody Production Market, by Antibody Type
6.1. Introduction
6.2. Monoclonal Antibodies
6.3. Polyclonal Antibodies
7. Antibody Production Market, by Process
7.1. Introduction
7.2. Downstream Processing
7.3.1. Chromatography Resins
7.3.2. Chromatography Systems
7.3. Filtration
7.4.1. Consumables & Accessories
7.4.2. Filtration Systms
7.4. Upstream Processing
7.5.1. Bioreactors
7.5.2. Consumables
8. Antibody Production Market, by End-User
8.1. Introduction
8.2. Contract Research Organizations (CROs)
8.3. Diagnostic Laboratories
8.4. Pharmaceutical & Biotechnology Companies
8.5. Research Institutes & Academic Centers
9. Americas Antibody Production Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Antibody Production Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Antibody Production Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AbbVie Inc.
13.1.2. Amgen Inc.
13.1.3. AstraZeneca PLC
13.1.4. Biogen Inc.
13.1.5. Bristol-Myers Squibb Company
13.1.6. Cell Signaling Technology, Inc.
13.1.7. Eppendorf AG
13.1.8. F. Hoffmann-La Roche Ltd.
13.1.9. Fibercell Systems Inc
13.1.10. GE HealthCare Technologies Inc.
13.1.11. Genmab A/S
13.1.12. GenScript Biotech Corporation
13.1.13. Gilead Sciences, Inc.
13.1.14. INTEGRA Biosciences AG
13.1.15. Merck KGaA
13.1.16. Novartis AG
13.1.17. Novo Nordisk A/S
13.1.18. Pall Corporation
13.1.19. Pfizer Inc.
13.1.20. ProteoGenix
13.1.21. Sanofi S.A.
13.1.22. Sartorius AG
13.1.23. Teva Pharmaceutical Industries Ltd.
13.1.24. The Antibody Company
13.1.25. Thermo Fisher Scientific Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. ANTIBODY PRODUCTION MARKET RESEARCH PROCESS
FIGURE 2. ANTIBODY PRODUCTION MARKET SIZE, 2023 VS 2030
FIGURE 3. ANTIBODY PRODUCTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ANTIBODY PRODUCTION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ANTIBODY PRODUCTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ANTIBODY PRODUCTION MARKET DYNAMICS
FIGURE 7. ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2023 VS 2030 (%)
FIGURE 8. ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
FIGURE 10. ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ANTIBODY PRODUCTION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ANTIBODY PRODUCTION MARKET SHARE, BY KEY PLAYER, 2023